Medical device innovations for cardiovascular, ophthalmologic and otolaryngologic applications

Medical device innovations for cardiovascular, ophthalmologic and otolaryngologic applications

The consortium RESPONSE is a cooperation between partners from science and industry within the BMBF-Program “Twenty20 - Partnership for Innovation”, 2014-2021. RESPONSE gives its partners opportunities to put medical device innovations into practice more efficiently. In order to accelerate innovatio...

Full description

Bibliographic Details
Main Authors: Grabow Niels, Senz Volkmar, Schmitz Klaus-Peter
Format: Article
Language:English
Published: De Gruyter 2019-09-01
Series:Current Directions in Biomedical Engineering
Subjects:
implant
combination product
cataract
glaucoma
eustachian tube
cochlea
fallopian tube
pancreas
Online Access:https://doi.org/10.1515/cdbme-2019-0030
Description
Summary:The consortium RESPONSE is a cooperation between partners from science and industry within the BMBF-Program “Twenty20 - Partnership for Innovation”, 2014-2021. RESPONSE gives its partners opportunities to put medical device innovations into practice more efficiently. In order to accelerate innovation processes, joint efforts are being made along the entire translation chain. RESPONSE is focusing on the development of novel concepts of implantable medical devices for cardiovascular, ophthalmologic and ENT application. Platform technology approaches are being used to extend the range of device applications. See also: www.response.uni-rostock.de
ISSN:2364-5504

Similar Items